Biodesix Expands Bio-Rad Partnership for Droplet Digital PCR Assay Development
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Breast |
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Emerging & Zoonotic Diseases |
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Lung Cancer |
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Cancer |
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read MorePosted by CLP Edit Staff | Oct 22, 2025 | Cervical (HPV) |
New automated workflow combines at-home sampling with robotic lab processing.
Read More